1214344-68-9Fc1ncc(C(F)(F)F)cn1QEWJTWUFYSMONN-UHFFFAOYSA-N1214344-68-9DTXSID90602138Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H301 (66.7%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses2-Fluoro-5-trifluoromethylpyrimidine is an important intermediate in pharmaceutical synthesis, used to synthesize fused-ring dihydrofurans. These dihydrofurans can act as modulators of the G protein-coupled receptor GPR119, used to treat diabetes, obesity, and dyslipidemia. Furthermore, 2-fluoro-5-trifluoromethylpyrimidine can also serve as an intermediate in the synthesis of drugs for treating Alzheimer's disease and schizophrenia.